Unknown

Dataset Information

0

STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.


ABSTRACT: Epithelial-mesenchymal transition (EMT)/mesenchymal-epithelial transition (MET) processes are proposed to be a driving force of cancer metastasis. By studying metastasis in bone marrow-derived mesenchymal stem cell (BM-MSC)-driven lung cancer models, microarray time-series data analysis by systems biology approaches revealed BM-MSC-induced signaling triggers early dissemination of CD133+/CD83+ cancer stem cells (CSCs) from primary sites shortly after STAT3 activation but promotes proliferation towards secondary sites. The switch from migration to proliferation was regulated by BM-MSC-secreted LIF and activated LIFR/p-ERK/pS727-STAT3 signaling to promote early disseminated cancer cells MET and premetastatic niche formation. Then, tumor-tropic BM-MSCs circulated to primary sites and triggered CD151+/CD38+ cells acquiring EMT-associated CSC properties through IL6R/pY705-STAT3 signaling to promote tumor initiation and were also attracted by and migrated towards the premetastatic niche. In summary, STAT3 phosphorylation at tyrosine 705 and serine 727 differentially regulates the EMT-MET switch within the distinct molecular subtypes of CSCs to complete the metastatic process.

SUBMITTER: Lin WH 

PROVIDER: S-EPMC7843420 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

STAT3 phosphorylation at Ser727 and Tyr705 differentially regulates the EMT-MET switch and cancer metastasis.

Lin Wei-Hsin WH   Chang Yi-Wen YW   Hong Min-Xiang MX   Hsu Te-Cheng TC   Lee Ko-Chuan KC   Lin Che C   Lee Jia-Lin JL  

Oncogene 20201201 4


Epithelial-mesenchymal transition (EMT)/mesenchymal-epithelial transition (MET) processes are proposed to be a driving force of cancer metastasis. By studying metastasis in bone marrow-derived mesenchymal stem cell (BM-MSC)-driven lung cancer models, microarray time-series data analysis by systems biology approaches revealed BM-MSC-induced signaling triggers early dissemination of CD133<sup>+</sup>/CD83<sup>+</sup> cancer stem cells (CSCs) from primary sites shortly after STAT3 activation but pr  ...[more]

Similar Datasets

2020-10-01 | GSE158824 | GEO
| PRJNA666659 | ENA
| S-EPMC7666735 | biostudies-literature
| S-EPMC5496498 | biostudies-other
| S-EPMC6237562 | biostudies-literature
| S-EPMC4181708 | biostudies-literature
| S-EPMC7797683 | biostudies-literature
| S-ECPF-GEOD-56898 | biostudies-other
| S-EPMC4359227 | biostudies-literature
| S-EPMC5045413 | biostudies-other